Effects of Fenofibrate Therapy in Diabetic Nephropathy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT03869931
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Registry
-
NCT03869931
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Singapore
- Registry status
- Unknown status
Technical summary
Registry record NCT03869931. Allocation not applicable; no masking; primary purpose treatment. Start 2019-03-08 (actual); primary completion 2021-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Fenofibrate Therapy in Diabetic Nephropathy
- Condition
- Diabetes Mellitus
- Condition
- Diabetic Nephropathies
- Intervention (Drug)
- Fenofibrate
- Lead sponsor
- Singapore General Hospital
- Collaborator
- National Medical Research Council (NMRC), Singapore
Record details
- Record id
cardio:ct-nct03869931- Content hash
a73eedab1b1895e42b1c23c79156c1087c8bcc3608318360735cd769daa8fbdb